|
Re: ESPR results
|
9
|
Resverlogix Corp.
|
Oct 28, 2018 11:28PM
|
|
Re: ESPR results
|
4
|
Resverlogix Corp.
|
Aug 27, 2018 09:49AM
|
|
Re: ESPR results
|
6
|
Resverlogix Corp.
|
Aug 26, 2018 12:58AM
|
|
Re: ESPR results
|
6
|
Resverlogix Corp.
|
Aug 26, 2018 10:41AM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 04:37PM
|
|
Re: Estimated Glomerular Filtration Rate
|
11
|
Resverlogix Corp.
|
Nov 17, 2019 05:08PM
|
|
Re: Estimated Glomerular Filtration Rate
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 06:11PM
|
|
Re: Estimated Glomerular Filtration Rate
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 06:14PM
|
|
Re: Estimated Glomerular Filtration Rate
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 06:53PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
2
|
Resverlogix Corp.
|
May 20, 2019 03:57PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
5
|
Resverlogix Corp.
|
May 27, 2019 03:28PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
4
|
Resverlogix Corp.
|
May 27, 2019 04:36PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
6
|
Resverlogix Corp.
|
May 27, 2019 05:02PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
4
|
Resverlogix Corp.
|
May 24, 2019 11:41AM
|
|
Re: European Atherosclerosis Society Congress May 29 - June 1
|
|
Resverlogix Corp.
|
May 30, 2016 07:35PM
|
|
Re: European Atherosclerosis Society Congress May 29 - June 1
|
3
|
Resverlogix Corp.
|
May 30, 2016 10:40AM
|
|
Re: European Atherosclerosis Society Congress May 29 - June 1
|
5
|
Resverlogix Corp.
|
May 26, 2016 01:36PM
|
|
Re: Evacetrapib fails
|
4
|
Resverlogix Corp.
|
May 18, 2017 08:49AM
|
|
Re: Evacetrapib fails
|
4
|
Resverlogix Corp.
|
May 18, 2017 11:02AM
|
|
Re: Events
|
4
|
Zenith Epigenetics
|
Apr 25, 2017 05:28PM
|
